Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBX 1,585.00
-9.00 (-0.56%)
Jul 31, 2026, 5:13 PM GMT
Hikma Pharmaceuticals Revenue
In the year 2025, Hikma Pharmaceuticals had annual revenue of $3.35B USD with 7.10% growth. Hikma Pharmaceuticals had revenue of $1.69B in the half year ending December 31, 2025, with 16.78% growth.
Revenue
$3.35B
Revenue Growth
+7.10%
P/S Ratio
1.34
Revenue / Employee
$356.28K
Employees
9,400
Market Cap
3.33B GBP
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.35B | 222.00M | 7.10% |
| Dec 31, 2024 | 3.13B | 252.00M | 8.77% |
| Dec 31, 2023 | 2.88B | 358.00M | 14.22% |
| Dec 31, 2022 | 2.52B | -36.00M | -1.41% |
| Dec 31, 2021 | 2.55B | 212.00M | 9.06% |
| Dec 31, 2020 | 2.34B | 134.00M | 6.07% |
| Dec 31, 2019 | 2.21B | 137.00M | 6.62% |
| Dec 31, 2018 | 2.07B | 134.00M | 6.92% |
| Dec 31, 2017 | 1.94B | -14.00M | -0.72% |
| Dec 31, 2016 | 1.95B | 510.00M | 35.42% |
| Dec 31, 2015 | 1.44B | -49.00M | -3.29% |
| Dec 31, 2014 | 1.49B | 124.00M | 9.08% |
| Dec 31, 2013 | 1.37B | 256.00M | 23.08% |
| Dec 31, 2012 | 1.11B | 190.98M | 20.80% |
| Dec 31, 2011 | 918.03M | 187.09M | 25.60% |
| Dec 31, 2010 | 730.94M | 94.05M | 14.77% |
| Dec 31, 2009 | 636.88M | 56.23M | 9.68% |
| Dec 31, 2008 | 580.66M | 131.86M | 29.38% |
| Dec 31, 2007 | 448.80M | 131.77M | 41.57% |
| Dec 31, 2006 | 317.02M | 54.81M | 20.90% |
| Dec 31, 2005 | 262.22M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Haleon | 11.15B |
| HUTCHMED (China) | 413.87M |
| ECO Animal Health Group | 87.53M |
| Allergy Therapeutics | 57.29M |
| Shield Therapeutics | 36.93M |
| Venture Life Group | 35.17M |
| Chill Brands Group | 955.18K |
| Provexis | 871.27K |
Hikma Pharmaceuticals News
- 11 days ago - Shares in Generic-Drug Makers Fall After Trump's Tariff Plan - WSJ
- 17 days ago - Hikma Pharmaceuticals initiated with a Buy at Citi - TheFly
- 2 months ago - Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma - PRNewsWire
- 2 months ago - US Supreme Court backs generic drugmaker in 'skinny label' patent case - Reuters
- 2 months ago - Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million - GlobeNewsWire
- 3 months ago - Hikma Pharmaceuticals Transcript: Trading update - Transcripts
- 3 months ago - Hikma Pharmaceuticals Earnings release: Trading update - Filings
- 3 months ago - UK's Hikma Pharmaceuticals reiterates 2026 outlook despite higher costs from Iran war - Reuters